Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting. - Zervanos, Damianos-Ioannis; Galatou, Eleftheria; Miliotou, Androulla N.; Theodoroula, Nikoleta F.; Grigoriadis, Nikolaos; Vizirianakis, Ioannis S. (Future Pharmacology, 2025)